Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 308, Issue 1, 2015, Pages R18-R27

  Chen, Jinghong ^a   Winston, John H ^a   Fu, Yu ^a   Guptarak, Jutatip ^a   Jensen, Kathryn L ^a   Shi, Xuan Zheng ^a   Green, Thomas A ^a   Sarna, Sushil K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Anxiety; Depression; Inflammatory bowel disease; Spontaneous activity in visceral afferent neurons; Visceral hypersensitivity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DEXTRAN SULFATE; LIDOCAINE; MESSENGER RNA; RESINIFERATOXIN; TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; DITERPENE; KCNA1 PROTEIN, RAT; KCNA4 PROTEIN, RAT; LOCAL ANESTHETIC AGENT; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.4; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; COLITIS; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; MALE; MEMBRANE STEADY POTENTIAL; NONHUMAN; PLACE PREFERENCE; PROTEIN EXPRESSION; RAT; SENSORY NERVE; SPINAL GANGLION; ULCERATIVE COLITIS; UPREGULATION; WHOLE CELL PATCH CLAMP; COMPARATIVE STUDY; DESENSITIZATION; DISEASE DURATION; DISEASE EXACERBATION; INTRACOLONIC DRUG ADMINISTRATION; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; SUCROSE PREFERENCE TEST; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; COLITIS, ULCERATIVE; COLON; COMPLICATION; CONDITIONING; DISEASE MODEL; DRUG EFFECTS; GENETICS; INNERVATION; METABOLISM; PATHOPHYSIOLOGY; PREVENTION AND CONTROL; PSYCHOLOGY; TIME FACTOR;

ABDOMINAL PAIN; ACTION POTENTIALS; ANESTHETICS, LOCAL; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; COLITIS, ULCERATIVE; COLON; CONDITIONING (PSYCHOLOGY); DEPRESSION; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DITERPENES; GANGLIA, SPINAL; KV1.1 POTASSIUM CHANNEL; KV1.4 POTASSIUM CHANNEL; LIDOCAINE; RATS; RNA, MESSENGER; TIME FACTORS; TRPV CATION CHANNELS;

EID: 84928647808     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00298.2014     Document Type: Article

References (37)

1. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol32: 1013–1021, 1997.
2. Amir R, Michaelis M, Devor M. Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain. J Neurosci19: 8589–8596, 1999.
3. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut28: 1600–1604, 1987.
4. Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain133: 433–447, 2010.
5. Bedi SS, Yang Q, Crook RJ, Du J, Wu Z, Fishman HM, Grill RJ, Carlton SM, Walters ET. Chronic spontaneous activity generated in the somata of primary nociceptors is associated with pain-related behavior after spinal cord injury. J Neurosci 30: 14,870–14,882, 2010.
6. Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res125: 141–149, 2001.
7. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, Lu J, Khan WI, Corthesy-Theulaz I, Cherbut C, Bergonzelli GE, Collins SM. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology139: 2102–2112, 2010.
8. Chapman V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain75: 261–272, 1998.
9. Chen J, Winston JH, Sarna SK. Neurological and cellular regulation of visceral hypersensitivity induced by chronic stress and colonic inflammation in rats. Neuroscience248C: 469–478, 2013.
10. Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol96: 1499–1506, 2001.
11. Davoody L, Quiton RL, Lucas JM, Ji Y, Keller A, Masri R. Conditioned place preference reveals tonic pain in an animal model of central pain. J Pain12: 868–874, 2011.
12. Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 26: 1281–1292, 2006.
13. Fiocchi C, Fukushima K, Strong SA, Ina K. Pitfalls in cytokine analysis in inflammatory bowel disease. Aliment Pharmacol Ther 10 Suppl 2: 63–69; discussion 70–61, 1996.
14. Goodhand JR, Wahed M, Mawdsley JE, Farmer AD, Aziz Q, Ramp-ton DS. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis18: 2301–2309, 2012.
15. Green TA, Alibhai IN, Hommel JD, DiLeone RJ, Kumar A, Theobald DE, Neve RL, Nestler EJ. Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J Neurosci26: 8235–8242, 2006.
16. Green TA, Alibhai IN, Roybal CN, Winstanley CA, Theobald DE, Birnbaum SG, Graham AR, Unterberg S, Graham DL, Vialou V, Bass CE, Terwilliger EF, Bardo MT, Nestler EJ. Environmental enrichment produces a behavioral phenotype mediated by low cyclic adenosine monophosphate response element binding (CREB) activity in the nucleus accumbens. Biol Psychiatry67: 28–35, 2010.
17. Kajander KC, Bennett GJ. Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons. J Neurophysiol68: 734–744, 1992.
18. King T, Vera-Portocarrero L, Gutierrez T, Vanderah TW, Dussor G, Lai J, Fields HL, Porreca F. Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci12: 1364–1366, 2009.
19. Lin C, Al-Chaer ED. Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain. Brain Res971: 73-82, 2003.
20. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis13: 225-234, 2007.
21. Minderhoud IM, Oldenburg B, Wismeijer JA, van Berge Henegou-wen GP, Smout AJ. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 49: 469–474, 2004.
22. Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, Tillinger W, Gangl A, Moser G. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med66: 79-84, 2004.
23. Pollmacher T, Haack M, Schuld A, Reichenberg A, Yirmiya R. Low levels of circulating inflammatory cytokines—do they affect human brain functions? Brain Behav Immun16: 525-532, 2002.
24. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia55: 453-462, 2007.
25. Sach J, Bolus R, Fitzgerald L, Naliboff BD, Chang L, Mayer EA. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients? Am J Gastroenterol97: 3131-3138, 2002.
26. Sarna SK. Enteric descending and afferent neural signaling stimulated by giant migrating contractions: essential contributing factors to visceral pain. Am J Physiol Gastrointest Liver Physiol292: G572-G581, 2007.
27. Schaefer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K. Interferon alpha (IFNa) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psych26: 731-746, 2002.
28. Serra J. Overview of neuropathic pain syndromes. Acta Neurol Scand Suppl173: 7-11; discussion 48-52, 1999.
29. Shi XZ, Winston JH, Sarna SK. Differential immune and genetic responses in rat models of Crohn’s colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol300: G41-G51, 2011.
30. Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain103: 249-257, 2003.
31. Verne GN, Sen A, Price DD. Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. J Pain6: 493-496, 2005.
32. Weng X, Smith T, Sathish J, Djouhri L. Chronic inflammatory pain is associated with increased excitability and hyperpolarization-activated current (Ih) in C- but not Adelta-nociceptors. Pain153: 900-914, 2012.
33. Winston JH, Xu GY, Sarna SK. Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress. Gastroenterology 138: 294-304 e293, 2010.
34. Wu G, Ringkamp M, Murinson BB, Pogatzki EM, Hartke TV, Weera-handi HM, Campbell JN, Griffin JW, Meyer RA. Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fi-ber afferents. J Neurosci22: 7746-7753, 2002.
35. Xiao WH, Bennett GJ. Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine. Pain135: 262-270, 2008.
36. Xiao WH, Bennett GJ. Persistent low-frequency spontaneous discharge in A-fiber and C-fiber primary afferent neurons during an inflammatory pain condition. Anesthesiology107: 813-821, 2007.
37. Zhou Q, Price DD, Verne GN. Reversal of visceral and somatic hypersensitivity in a subset of hypersensitive rats by intracolonic lidocaine. Pain139: 218-224, 2008.